MSCs treatment significantly reduced inflammatory cell infiltration, collagen deposition, and the expression of fibrosis-related proteins α-SMA and COL1A1 in the lung tissue of SSc mice (Figure 4). Here, ACTA1 is linked to systemic sclerosis.